Which Prenatal Genetic Diagnosis Test Comes When? CVS vs Amniocentesis Timing and Sampling

The envelope from the screening lab is thin, and the number inside is not the number anyone wanted. A couple sits at a kitchen table at 12 weeks, phone between them, trying to work out what “higher chance” means and what the two words the midwife used, CVS and amniocentesis, actually involve. One can be done now. The other means waiting three more weeks. Neither sounds pleasant.

The cvs vs amniocentesis question is, at heart, a question about the calendar and the tissue. Both procedures pull a tiny sample from the pregnancy so a laboratory can look directly at the baby’s chromosomes. They simply do it at different points in the pregnancy and from different places: one from the developing placenta, the other from the fluid that surrounds the baby.

What follows is a plain account of which test is offered when, what each one feels like, what the results can and cannot say, and where the trade-offs lie, so that the conversation with your obstetrician or genetic counselor starts from solid ground rather than guesswork.

What are CVS and amniocentesis, and why does pregnancy need two tests?

Most people meet these two tests only after a screening result comes back higher than expected, or because a family history makes a specific genetic condition more likely. Screening tests, such as the first-trimester blood test and ultrasound or cell-free DNA testing, estimate a chance. Diagnostic tests answer the question. CVS and amniocentesis are the two diagnostic tests, and each collects cells that carry the baby’s genetic material.

Chorionic villus sampling, usually shortened to CVS, takes a small piece of the chorionic villi, which are finger-like projections of the early placenta that share the baby’s genetic makeup. Amniocentesis draws a small amount of amniotic fluid, the liquid cushioning the baby inside the sac, which contains skin and other cells the baby has shed. Both samples go to a laboratory where the chromosomes are examined and, when needed, specific genes are tested.

Why two? Timing is the main reason. The placenta is well enough developed to sample safely from late in the first trimester, while amniotic fluid is not reliably plentiful or safe to sample until the second trimester. Having both options means a person who wants an answer at 12 weeks and a person whose concern arises at 18 weeks can each be offered something appropriate. The NHS describes CVS as usually carried out between 11 and 14 weeks, and amniocentesis as usually carried out between 15 and 20 weeks, though both can sometimes be done later if a new question arises.

Neither test is routine for everyone, and neither is compulsory. The NHS and Mayo Clinic both frame them as offered, not required: the decision to have one, both, or none belongs to the pregnant person after a discussion of benefits and risks with the care team.

CVS vs amniocentesis: the timing window, week by week

Think of the first half of pregnancy as a corridor with two doors. The first door, CVS, opens at roughly 11 weeks and is usually used up to about 14 weeks. The second, amniocentesis, opens at about 15 weeks and stays open for the rest of the second trimester and beyond. There is a short stretch, roughly 14 to 15 weeks, where teams are often reluctant to use either, and that gap is not arbitrary.

Before 10 weeks, CVS has been linked in older studies with a small increase in limb differences in the baby, which is why the Mayo Clinic notes that the procedure is not done before that point. After about 14 weeks the placenta remains accessible, but by then amniotic fluid is becoming the preferred sample because it reflects the baby’s own cells rather than placental cells, which sidesteps a complication discussed later in this article.

Amniocentesis, for its part, is not usually performed before 15 weeks. The NHS explains that early amniocentesis carries a higher chance of complications, including a higher rate of talipes (clubfoot), and that the volume of fluid before 15 weeks is smaller and harder to sample safely. From 15 weeks onward the fluid is more plentiful and the risk profile settles.

In practice, then, the choice is often made for you by the date of the referral. Someone whose combined screening test at 12 weeks returns a higher chance can be offered CVS almost immediately. Someone whose 20-week ultrasound shows an unexpected finding will be offered amniocentesis, because the CVS window has passed. Someone whose cell-free DNA result arrives at 13 weeks sits close to the boundary and may be given a genuine choice between doing CVS now or waiting about two weeks for amniocentesis.

What actually happens during a CVS test

The room looks like an ordinary ultrasound suite, and the appointment usually begins with a scan to confirm how far along the pregnancy is, where the placenta sits, and how the baby is lying. That position dictates the route. There are two ways to reach the placenta, and the doctor chooses whichever offers the safest, most direct path.

The transabdominal route goes through the abdomen. The skin is cleaned, a local anesthetic is sometimes offered, and a thin needle is passed through the abdominal wall and uterine wall into the placenta under continuous ultrasound guidance. A small amount of villus tissue is drawn into a syringe. The transcervical route uses a fine tube or forceps passed through the vagina and cervix to the placenta, again guided by ultrasound. Which one is used depends mostly on placental position; the Mayo Clinic notes that a low-lying placenta may favor the cervical approach.

The sampling itself is brief. The NHS describes the whole procedure as taking about 10 minutes, though the appointment, with scan, consent and observation afterward, takes longer. Most people report a sharp or cramping sensation similar to a strong period pain rather than severe pain. The baby’s heartbeat is checked afterward, and people are usually advised to rest for the remainder of the day.

A small point that often surprises people: the needle does not enter the sac around the baby during CVS. The target is the placenta alone. That is part of why CVS is possible early, while the sac is still small. The sample then travels to a genetics laboratory, where two types of analysis begin, a rapid one and a fuller one, described in a later section.

What happens during amniocentesis at 15 weeks and beyond

Amniocentesis follows a similar rhythm but a different target. After a scan to locate the baby and a pocket of fluid safely away from the baby and the umbilical cord, the abdomen is cleaned and a thin, hollow needle is guided through the abdominal and uterine walls into the amniotic sac. A small amount of fluid, described by the NHS as around 15 milliliters and by the Mayo Clinic as roughly two to four teaspoons, is withdrawn. The body replaces that fluid over the following hours.

Local anesthetic is not always used, because the needle is fine and the injection itself can sting as much as the procedure. The Mayo Clinic describes the sensation as stinging as the needle enters the skin and cramping as it enters the uterus. The needle is usually in place for well under a minute. Afterward the baby’s heartbeat is checked on ultrasound before the person leaves.

The fluid contains cells that the baby has shed, mostly from skin and the urinary tract, along with proteins and other substances. The cells are the genetic sample. Some are used for a rapid test that looks at the most common chromosomal conditions, and the rest are grown in the laboratory for several days so that a full chromosome picture, or a more detailed molecular test, can be obtained.

Because amniocentesis samples the baby’s own cells rather than placental tissue, the result is generally considered a direct reflection of the baby’s genetic makeup. The trade-off is time: the pregnancy must reach about 15 weeks before the procedure is offered, and the full results typically take another two to three weeks according to the NHS, so the complete answer often arrives at around 17 to 19 weeks or later.

Who is usually offered a diagnostic test, and who is usually asked to wait

Neither test is offered to every pregnant person, because both carry a small but real chance of miscarriage. Care teams reserve them for situations where the chance of finding a condition is high enough to justify that risk, or where the pregnant person, fully informed, wants certainty regardless.

Common reasons for an offer, drawn from NHS and Mayo Clinic guidance, include a screening result indicating a higher chance of a chromosomal condition such as Down syndrome; a positive cell-free DNA screening result, which is itself a screening test and not a diagnosis; an ultrasound finding that raises concern; a previous pregnancy affected by a chromosomal or genetic condition; and a known inherited condition in one or both parents, such as cystic fibrosis or sickle cell disease, where a specific gene can be tested. Age on its own is less often the sole trigger than it once was, now that screening tests are widely available.

Who is asked to wait, or offered a different path? Someone at 14 weeks may be asked to wait a week or two for amniocentesis rather than have CVS at the edge of its window. Someone with an active vaginal infection may have the procedure postponed until it is treated. Someone with a low-lying placenta may be steered to one CVS route over another. A person carrying twins can have either test, but the Mayo Clinic notes that multiple pregnancies make the procedures more complex, so they are usually done by teams experienced in sampling each sac or placenta separately.

Some people are offered a test and decline, preferring to continue with screening or with no further testing. That is a legitimate choice, and the NHS is explicit that the tests are optional. The care team’s job is to lay out the options; the decision remains with the pregnant person.

CVS vs amniocentesis at a glance

Laid side by side, the two tests are more alike than different. Both are diagnostic rather than screening, both are guided by ultrasound, both take minutes to perform, and both send cells to the same kind of laboratory. The meaningful differences sit in the timing, the tissue, and one wrinkle in interpretation.

Feature	CVS	Amniocentesis
Usual timing	About 11 to 14 weeks (NHS)	About 15 to 20 weeks, sometimes later (NHS)
What is sampled	Chorionic villi from the placenta	Amniotic fluid containing the baby’s shed cells
Route	Through the abdomen or through the cervix	Through the abdomen
Sampling time	Around 10 minutes (NHS)	Needle in place under a minute; visit about 10 minutes (NHS)
Rapid result	Within about 3 working days (NHS)	Within about 3 working days (NHS)
Full result	Around 2 to 3 weeks (NHS)	Around 2 to 3 weeks (NHS)
Miscarriage risk	Small; see next section	Small; see next section
Interpretation caveat	Placental mosaicism can occasionally give an unclear result	Reflects the baby’s own cells; unclear results less common
Neural tube protein test	Not possible from villi	Alpha-fetoprotein in fluid can be measured

Two rows deserve a second look. The interpretation caveat for CVS exists because the placenta and the baby grow from the same fertilized egg but can occasionally develop small genetic differences; the placenta is not the baby. And amniocentesis can measure a protein called alpha-fetoprotein in the fluid, which historically helped assess the chance of certain spinal conditions, though detailed ultrasound now does much of that work.

What the table does not show is the emotional weight of the gap between the columns. Three or four weeks of waiting is not a small thing at this stage, and it is often the deciding factor for people who are eligible for both tests.

CVS or amnio: which is safer? What the evidence shows about miscarriage

This is the question almost everyone asks first, and the honest answer is that the two tests now appear to carry similar, small risks, with the figures depending heavily on which studies are counted and how the baseline miscarriage rate at that stage of pregnancy is handled.

The NHS quotes an additional miscarriage risk of up to 1 in 100 for both CVS and amniocentesis, and notes that this figure comes from older data and that more recent evidence suggests the risk may be lower. The Mayo Clinic, drawing on newer analyses, puts the risk of miscarriage after second-trimester amniocentesis at roughly 0.1 to 0.3 percent, and describes the risk after CVS as similar, in the region of two per thousand. These are added risks on top of the background chance of miscarriage that exists at that stage of any pregnancy, which is one reason the numbers are hard to pin down precisely.

The mechanism is not fully understood. Infection introduced by the needle, leakage of amniotic fluid, bleeding, and premature rupture of membranes are the proposed pathways, and each is uncommon. The Mayo Clinic notes that fluid leakage after amniocentesis is usually small and often resolves on its own, though persistent leakage needs assessment.

What the evidence does not support is a strong claim that one test is clearly safer than the other. Older comparisons suggested CVS carried a slightly higher risk, but that gap has narrowed as technique and ultrasound guidance have improved. The factor most consistently associated with lower risk in the published literature is the experience of the operator and the unit, which is why these procedures are concentrated in fetal medicine services.

For the person at the kitchen table, the practical reading is this: the miscarriage risk for either test is small, is roughly comparable, and should be weighed against how much the answer matters to you and how it might change your care. That weighing is personal, and the care team can help you do it without pushing either way.

What the results can tell you, and what they cannot

Two kinds of results usually arrive from either test, at two different speeds. The first is a rapid test, often called QF-PCR, a laboratory technique that counts copies of a handful of specific chromosomes. It checks for the most common chromosomal conditions: Down syndrome (an extra copy of chromosome 21), Edwards syndrome (chromosome 18), Patau syndrome (chromosome 13), and sometimes the sex chromosomes. The NHS says these first results are usually available within about 3 working days.

The second is the fuller analysis. Traditionally this was a karyotype, a photograph-like map of all 46 chromosomes made by growing the cells for several days. Increasingly it is a chromosomal microarray, a test that scans the whole genome for small missing or extra pieces too small to see on a karyotype. When there is a known family condition, a targeted gene test looks at that one gene. The NHS gives around 2 to 3 weeks for these fuller results.

What the tests cannot do is equally important. Neither CVS nor amniocentesis screens for every possible genetic condition; there are thousands, and most are not tested unless specifically requested. Neither test can tell you how severely a detected condition will affect a particular child; the same chromosomal finding can look very different from one person to another. Neither test detects structural differences of the body, which is the job of ultrasound. And neither test can guarantee a healthy baby, because most health problems in childhood are not chromosomal at all.

Occasionally a microarray finds a change whose significance is uncertain, a so-called variant of uncertain significance. Genetic counselors spend a good deal of time explaining these, and it is one reason many teams ask people before the test what level of detail they want reported.

Why a CVS result sometimes needs a second look

Here is the wrinkle mentioned earlier. CVS samples the placenta, and although the placenta and baby share an origin, a small proportion of placentas develop cells with a different chromosome count from the baby. This is called confined placental mosaicism: mosaicism means a mixture of cells with different genetic makeups, and confined means the mixture is limited to the placenta.

When the laboratory sees two cell lines in a CVS sample, it cannot be sure from the villi alone whether the baby shares the finding. The NHS notes that in around 1 in 100 CVS procedures the result is unclear, and the usual next step is to offer amniocentesis once the pregnancy reaches 15 weeks, because amniotic fluid contains the baby’s own cells. Mosaicism can also occasionally appear in amniotic fluid, but it is considerably less common there and is more likely to reflect the baby.

The other rare cause of a puzzling CVS result is maternal cell contamination, where a few of the pregnant person’s own cells end up in the sample. Laboratories screen for this routinely, and if suspected, the test may be repeated or amniocentesis offered.

None of this makes CVS unreliable. For the great majority of people, the CVS result is clear and final, and the earlier timing is exactly what they wanted. But it does explain two things you may hear from your team. First, why some units lean toward amniocentesis when the timing is borderline. Second, why a CVS result showing mosaicism is not a diagnosis of the baby but a prompt for a further test. Understanding that distinction ahead of time can spare a great deal of alarm if the phone call turns out to be “we need another sample” rather than “here is your answer.”

How screening tests fit before a diagnostic test

Most people arrive at the CVS or amniocentesis conversation through a screening test, and it helps to know what those tests do and do not establish. Screening estimates a chance. Diagnosis establishes a fact. The distinction sounds academic until a report says “high risk” and you are deciding whether to take a small procedural risk to find out.

The combined test, offered at about 11 to 14 weeks in many health systems including the NHS, pairs an ultrasound measurement of fluid at the back of the baby’s neck with two blood markers and the pregnant person’s age to produce a chance for Down, Edwards and Patau syndromes. A quadruple blood test later in pregnancy does a similar job for Down syndrome when the first-trimester window is missed.

Cell-free DNA testing, often called non-invasive prenatal testing or NIPT, analyzes fragments of placental DNA circulating in the pregnant person’s blood, usually from about 10 weeks. It is highly accurate as a screen for the common trisomies, and MedlinePlus is clear that it remains a screening test: a positive result should be confirmed by CVS or amniocentesis before any decision is made, because false positives occur, and because the DNA being measured comes from the placenta, with the same mosaicism caveat that applies to CVS.

Ultrasound is the other route in. Detailed anomaly scans at around 18 to 21 weeks can pick up structural findings that raise the chance of a chromosomal condition, and these findings are a common reason for amniocentesis in the second trimester.

The sequence, then, usually runs screening first, then a discussion of whether the chance is high enough to warrant diagnosis, then CVS or amniocentesis depending on how many weeks have passed. Skipping straight to a diagnostic test is possible, and some people with a known family condition do exactly that, but for most it is the second step rather than the first.

Rh status, infections and other checks before the needle

A few practical matters are settled before either procedure, and knowing about them removes surprises on the day. The most important is blood group. If the pregnant person is Rh negative, meaning their red blood cells lack the Rh D protein, and the baby may be Rh positive, a small amount of the baby’s blood entering the pregnant person’s circulation during the procedure could prompt the immune system to make antibodies that affect this or a future pregnancy. To prevent that, the NHS and Mayo Clinic both describe offering an injection of anti-D immunoglobulin, a preparation of antibodies that mops up any fetal red cells before the immune system reacts, after CVS or amniocentesis. Whether it is needed, and its timing, is decided by the clinical team.

Infection is the second consideration. The procedures are done with sterile technique, and the risk of introducing infection into the uterus is very low; the Mayo Clinic describes it as rare. An active vaginal infection may lead the team to postpone a transcervical CVS in particular. Some units ask about blood-borne infections such as HIV or hepatitis, because in specific circumstances the procedure can be planned to minimize any chance of transmission, again a decision for the treating team.

Medication review is routine. People taking blood-thinning medicines are asked to tell the team beforehand, because bleeding risk is part of the planning; any change to such a medicine is the prescribing clinician’s decision, never something to do on your own.

Finally, consent. This is not a formality. The person performing the procedure, or a genetic counselor, should have explained the purpose of the test, what it can and cannot find, the miscarriage risk, the possibility of an unclear result, and the options if a condition is found. If any of that feels rushed, it is entirely reasonable to ask for more time before signing.

What the following days and weeks usually look like

The procedure ends, the heartbeat is checked, and then comes the part nobody prepares you for: going home to wait. The physical side is usually straightforward. Most people feel crampy for a few hours, and the NHS and Mayo Clinic both suggest taking it easy for the rest of the day and avoiding strenuous activity, heavy lifting and sexual intercourse for a day or two, or as advised by your team. A little spotting after transcervical CVS is common and usually settles. Mild pain relief may be suggested; which one, and whether any is needed, is for the team to advise.

Around day three, the rapid result arrives, usually by phone from a midwife, doctor or genetic counselor. Because this covers the most common conditions, for many people it is effectively the answer they were waiting for. The fuller result, whether karyotype or microarray, follows in about two to three weeks according to the NHS, and it can occasionally raise a new question of its own.

The emotional side is less predictable. Some people find the waiting harder than the procedure. Others feel a strange calm once the sample is taken, because the decision to test is behind them. Partners often describe feeling sidelined during the procedure and unsure how to help afterward; having a clear plan for how and when results will be delivered, and who will be present, tends to help everyone.

If the result shows a condition, the next appointment is typically with a genetic counselor or fetal medicine specialist, who explains what is known about the condition, what further tests or scans might add information, and what the options are. That conversation is unhurried by design. No decision needs to be made on the phone, and the NHS describes support services being available whichever path a family chooses.

What people often get wrong about CVS and amniocentesis

Several ideas circulate about these tests that do not match the evidence, and correcting them tends to lower the temperature of the decision.

“A positive NIPT result is a diagnosis.” It is not. Cell-free DNA testing is a screening test, however accurate. MedlinePlus and the Mayo Clinic both state that a positive screen needs confirmation by CVS or amniocentesis, because false positives happen and because the DNA measured comes from the placenta.

“The needle could hit the baby.” Both procedures are performed under continuous ultrasound, and the needle is guided into a pocket of fluid or into the placenta well away from the baby. Injury to the baby is described by the Mayo Clinic as very rare. During CVS the needle does not enter the sac at all.

“Amniocentesis is far safer than CVS.” Older data suggested a gap; newer analyses cited by the Mayo Clinic put both risks in a similar, small range. The bigger difference is timing, not safety.

“A normal result means a healthy baby.” A normal result means the specific chromosomes or genes tested look typical. It does not rule out other genetic conditions, structural differences, or the many childhood health problems that have nothing to do with chromosomes.

“You have to decide what to do before you test.” Many people test simply to know, to prepare, or to plan the birth. Diagnosis does not commit anyone to any particular course.

“Bed rest afterward prevents miscarriage.” There is no evidence that strict bed rest changes the outcome. Guidance is to rest for the day and avoid strenuous activity briefly, then resume normal life while watching for warning signs.

“An unclear CVS result means something is wrong.” It usually means placental mosaicism, and amniocentesis often shows the baby’s cells are typical.

Questions to ask your care team about CVS test timing and beyond

A good consultation leaves you with fewer questions than you walked in with. If it does not, these are worth raising. They are not a script; pick the ones that matter to you.

• Given how many weeks I am, am I eligible for CVS, amniocentesis, or both, and what would you weigh in choosing between them?
• Exactly what conditions will this test look for, and what will it not look for?
• Will I have a rapid result and a full result, and roughly when should I expect each?
• Would you recommend a karyotype, a microarray, or a targeted gene test in my situation, and what are the differences in what they can find?
• If the microarray finds a change of uncertain significance, do I want to be told, and how will you explain it?
• What is the miscarriage risk in this unit, and how is it measured?
• How likely is an unclear result, and what would happen next if I get one?
• Am I Rh negative, and will I need anti-D immunoglobulin afterward?
• Are there any medicines I take that you need to know about before the procedure?
• How will the results be delivered, to whom, and can I choose who is present?
• If a condition is found, who will I see next, and how quickly?
• What support is available whatever the result and whatever I decide?
• If I choose not to test, what monitoring would you suggest instead?

Write the answers down or ask for them in writing. People consistently underestimate how much of a genetics consultation they will forget by the time they reach the car park. A second appointment to go over the plan before the procedure is a reasonable request, and most services will accommodate it.

When to call your doctor after CVS or amniocentesis

Most people go home from either procedure with mild cramping and nothing more, and it settles within a day. A small number develop symptoms that need same-day assessment, and the NHS and Mayo Clinic are consistent about what those are.

Contact your maternity unit or doctor promptly, without waiting for a routine appointment, if you notice any of the following:

• Fluid leaking from the vagina, whether a trickle or a gush, which may indicate the amniotic sac is leaking after amniocentesis.
• Vaginal bleeding heavier than light spotting, or spotting that continues beyond a day or two, or any bleeding after transabdominal sampling.
• Abdominal pain or cramping that is severe, worsening, or persists beyond the first day rather than easing.
• A fever, chills, or feeling generally unwell, which can be early signs of infection in the uterus.
• Contractions, or a tightening of the abdomen that comes and goes in a pattern.
• Redness, warmth, swelling or discharge at the needle site.
• Later in pregnancy, a change in the baby’s movements after the procedure that concerns you.

Teams would rather hear about a symptom that turns out to be nothing than miss one that matters, and maternity units are set up to take these calls at any hour. Keep the contact number you were given somewhere you can find it quickly, and if you cannot reach your unit and symptoms are severe, use your local emergency service.

If none of these occur, the plan is simply to wait for the results call, resume normal activity as advised, and keep your usual antenatal appointments. Any decision about further testing, the timing of a repeat procedure, or changes to your care rests with the team looking after you, who will have the full picture of your pregnancy in front of them.

Frequently asked questions

What is the difference between CVS and amniocentesis?

CVS samples a tiny piece of the placenta, while amniocentesis samples the fluid around the baby. CVS is done earlier, usually 11 to 14 weeks; amniocentesis is done from about 15 weeks onward. Both are diagnostic tests for chromosomal and some genetic conditions, both are ultrasound-guided needle procedures, and both carry a small miscarriage risk. The main practical difference is timing, with a secondary difference in how often results need a second look.

How many weeks is CVS test timing, and can it be done later?

CVS is usually carried out between 11 and 14 weeks of pregnancy, according to the NHS. It is not done before 10 weeks because of a historical association with limb differences. It can occasionally be done after 14 weeks if the placenta is accessible, but by then most teams prefer amniocentesis because amniotic fluid contains the baby’s own cells and avoids the placental mosaicism issue.

Why is amniocentesis at 15 weeks the earliest usual time?

Before about 15 weeks the amniotic fluid volume is smaller and harder to sample safely, and studies of early amniocentesis found a higher rate of complications, including talipes or clubfoot, according to the NHS. From 15 weeks onward the fluid is more plentiful and the risk settles into the small range quoted for the procedure. Teams therefore usually schedule amniocentesis from 15 weeks.

CVS or amnio: which is safer for the baby?

Current evidence suggests the two carry similar, small risks. The NHS quotes an additional miscarriage risk of up to 1 in 100 for either, noting the figure comes from older data and may be lower. The Mayo Clinic cites newer estimates of about 0.1 to 0.3 percent for second-trimester amniocentesis and a comparable figure for CVS. Operator experience is the factor most consistently linked to lower risk.

How long do CVS and amniocentesis results take?

A rapid result covering the common chromosomal conditions, Down, Edwards and Patau syndromes, is usually available within about 3 working days for either test, according to the NHS. The fuller analysis, a karyotype or chromosomal microarray, takes around 2 to 3 weeks. Targeted tests for a specific family condition vary. Your team will tell you how and when each result will be delivered.

Does CVS or amniocentesis hurt?

Most people describe a sharp sting as the needle passes through the skin and a cramping sensation, similar to a strong period pain, as it enters the uterus. The needle is in place for well under a minute in amniocentesis and the CVS sampling takes about 10 minutes according to the NHS. Local anesthetic is sometimes offered. Mild cramping for a few hours afterward is common.

What does an unclear CVS result mean?

It usually means the placental sample contained a mixture of cells with different chromosome counts, known as confined placental mosaicism, or occasionally that a few maternal cells were mixed in. It is not a diagnosis of the baby. The NHS notes this happens in around 1 in 100 CVS procedures, and the usual next step is amniocentesis from 15 weeks to examine the baby’s own cells.

Can I have CVS or amniocentesis with twins?

Yes, both procedures can be performed in twin and other multiple pregnancies, but they are more complex because each placenta or sac usually needs to be sampled separately and the samples must be correctly matched to each baby. The Mayo Clinic notes multiples make the procedures more involved, so they are typically carried out by fetal medicine teams experienced in multiple pregnancies.

What conditions can chorionic villus sampling weeks 11 to 14 detect?

CVS can diagnose chromosomal conditions such as Down, Edwards and Patau syndromes, sex chromosome differences, and, with microarray, smaller missing or extra pieces of chromosomes. When a specific inherited condition runs in the family, such as cystic fibrosis or sickle cell disease, a targeted gene test can be done. It does not screen for every genetic condition and cannot detect structural differences, which ultrasound assesses.

Do I have to decide anything before having a diagnostic test?

No. Many people test simply to know, to prepare emotionally, to plan the birth, or to arrange care for a baby with a condition. A diagnosis does not commit you to any course of action. The NHS describes the tests as optional and the results as information to support whatever decision, if any, you make with your care team afterward.

References

• NHS: Amniocentesis
• NHS: Chorionic villus sampling (CVS)
• MedlinePlus: Prenatal Testing

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.